[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100580715":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":26,"locations":33,"responsibleParty":50,"collaborators":31,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":31,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":60,"maxAge":31,"enrollmentInfo":61,"targetDuration":31,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":31,"overallStatus":36,"whyStopped":31,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"University of Wisconsin, Madison","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"CBD for urinary incontinence","EXPERIMENTAL","Participants will take CBD for 90 days",[13],"Drug: CBD",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","CBD","Twice daily 100mg cannabidiol (CBD)",[9],[21],"Epidiolex",[23],{"name":24,"affiliation":5,"role":25},"Javi Santiago","PRINCIPAL_INVESTIGATOR",[27],{"name":28,"role":29,"phone":30,"phoneExt":31,"email":32},"Maria Flory","CONTACT","608-262-8652",null,"flory@ortho.wisc.edu",[34],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"University of Wisconsin - Madison","RECRUITING","Madison","Wisconsin","53705","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-89.40123,43.07305,{"lat":46,"lon":45},[49],{"name":28,"role":29,"phone":30,"phoneExt":31,"email":32},{"type":51,"investigatorFullName":31,"investigatorTitle":31,"investigatorAffiliation":31,"oldNameTitle":31,"oldOrganization":31},"SPONSOR","100580715","phase-2-cbd-for-lower-urinary-tract-dysfunction-in-spinal-cord-injury-100580715",false,"NCT06840899","CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury","Cannabinoid Modulation for Neurogenic Lower Urinary Tract Dysfunction in Spinal Cord Injury","Inclusion Criteria:\n\n* \\>18 years of age\n* History of supra-sacral spinal cord injury of any mechanism\n* Urinary incontinence with ≥2 episodes of urinary incontinence per day (outside of spinal shock)\n* Willingness to participate in drug intervention trial\n* English-speaking (able to provide consent and complete questionnaires)\n\nExclusion Criteria:\n\n* History of intravesical Botox\n* Actively taking \\>15 mg of Oxybutynin single dose or equivalent dose of alternative anticholinergic medication for bladder symptoms\n* Use of Cannabis (any form) outside of study as determined by urine drug screen after washout period of 1 month if prior Cannabis use reported\n* Thought or mood disorder aside from depression","ALL","18 Years",{"count":62,"type":63},20,"ESTIMATED","INTERVENTIONAL",[66],"PHASE2","The goal of this feasibility study is to learn whether Cannabidiol (CBD) can improve urinary incontinence and other symptoms in people with recent spinal cord injury (SCI).\n\nParticipants will take Epidiolex (purified CBD) for 90 days",[69,70,71],"Supra-sacral Spinal Cord Injury","Spinal Cord Injury","Urinary Incontinence","2026-03-02",{"date":74,"type":75},"2026-03-04","ACTUAL",{"date":77,"type":75},"2026-02-13",{"date":79,"type":63},"2027-05",{"name":5,"class":6},1]